NCT00748059

Brief Summary

The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Dec 1996

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1996

Completed
11.8 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 8, 2008

Completed
12.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

May 12, 2021

Status Verified

May 1, 2021

Enrollment Period

24 years

First QC Date

September 5, 2008

Last Update Submit

May 7, 2021

Conditions

Keywords

autonomic nervous system diseasesblood pressurecongenitalorthostasiscatecholamines

Outcome Measures

Primary Outcomes (1)

  • hemodynamic changes with standing

    following test

Secondary Outcomes (9)

  • blood and urine hormones

    after test

  • blood volume

    during supine and/or upright postures

  • sympathetic nerve activity

    during stimulation of sympathetic nervous system

  • quantitative sweat testing

    2 hours

  • Eye function

    once

  • +4 more secondary outcomes

Study Arms (1)

A

EXPERIMENTAL

Patients with Orthostatic Hypotension

Procedure: Standing or upright tiltProcedure: MicroneurographyProcedure: QSweatDevice: neck cuff stimulationDrug: phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramineDrug: clonidine,yohimbine,metoclopramide,alpha-methyldopaProcedure: BodPodProcedure: Eye examProcedure: Sleep studyProcedure: Pain response testingProcedure: Metabolic chamberProcedure: Brain function studiesProcedure: Bicycle Exercise Test

Interventions

stand upright or tilt table test

A

Recording from sympathetic nerve

A
QSweatPROCEDURE

quantitative sweat testing

A

Blood pressure receptors in the neck arteries may be stimulated by applying suction through a collar around the neck.

A

IV Pharmacological Testing phenylephrine 12.5 - 400 ug, isoproterenol 0.1 - 0.4 ug or higher until desired effect, nitroprusside 0.1 - 1.6 ug/kg, propranolol 1.1 mg/min, edrophonium maximum of 10 mg, atropine .01 mg/kg, tyramine 250-4000 ug or higher until desired effect

A

Oral Pharmacological Testing clonidine 0.1-0.3 mg, yohimbine 5-10 mg, metoclopramide 10 mg, alpha-methyldopa 62.5 mg, placebo

A
BodPodPROCEDURE

Determination of body composition

A
Eye examPROCEDURE

Examination of pressure in the eye and eyelid fatiguability. The following eyedrops might be used: 1. 0.5% proparacaine (Alcaine, Allergan, Inc) 2. Fluress (0.4% benoxinate hydrochloride, fluorescein sodium, Akorn, Inc) 3. 0.5%, 1% tropicamide (Mydriacyl, Alcon) 4. Over-the-counter preservative-free artificial tears 5. 0.25%, 2.5% and 10% phenylephrine (Bausch and Lomb) 6. 1% cyclopentolate hydrochloride (Alcon)

A
Sleep studyPROCEDURE

Recording of sleep pattern overnight

A

Subjects will rate the quality and intensity of 2 pain tasks.

A

Determination of metabolic rate via 24hr stay in whole-room indirect calorimeter

A

Questionnaires and computer tasks, an EEG and an MRI may be used to assess brain function.

A

Blood pressure and heart rate may be monitored while exercising on a stationary bicycle.

A

Eligibility Criteria

Age12 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • severe orthostatic hypotension and other autonomic symptoms but do not meet criteria for standard diagnosis
  • non-smokers
  • drug-free
  • able to give informed consent
  • free of pulmonary, renal, hematopoietic, hepatic and cardiac disease

You may not qualify if:

  • medications affecting the autonomic nervous system
  • any chronic illness
  • anemia (Hct\<30)
  • women of childbearing age who are pregnant or nursing
  • smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University

Nashville, Tennessee, 37232, United States

Location

Related Publications (1)

  • Arnold AC, Garland EM, Celedonio JE, Raj SR, Abumrad NN, Biaggioni I, Robertson D, Luther JM, Shibao CA. Hyperinsulinemia and Insulin Resistance in Dopamine beta-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2017 Jan 1;102(1):10-14. doi: 10.1210/jc.2016-3274.

MeSH Terms

Conditions

Autonomic Nervous System DiseasesHypotension, Orthostaticdopamine beta hydroxylase deficiencyOrthostatic IntoleranceDizziness

Interventions

Standing PositionPhenylephrineClonidine

Condition Hierarchy (Ancestors)

Nervous System DiseasesPrimary DysautonomiasHypotensionVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSensation Disorders

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaEthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesImidazolinesImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Emily M Garland, PhD

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

September 5, 2008

First Posted

September 8, 2008

Study Start

December 1, 1996

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

May 12, 2021

Record last verified: 2021-05

Locations